Global Medical Director Immunology and Inflammation - Nemolizumab

Galderma

Barcelona, Spain

The Global Medical Director Immunology and Inflammation - Nemolizumab is a subject matter expert in charge of providing the medical support to the development and execution of the global medical plan related to nemolizumab pre and post launch medical strategy in close collaboration with the Global Medical Indication Lead and the Head of Medical Strategy

This individual will strategically lead different part of the nemolizumab medical plan, including oversight and management of the phase 4 program for nemolizumab.

The candidate will need to have 8+ years of experience in medical affairs with previous global launch, biologic or advanced systemic therapies in the field of immunology (dermatology preferred), medical study management experience and strong leadership and strategic thinking skills.

He/she needs to act, behave, and deliver accordingly with high level of internal and external collaboration and engagement to enhance overall Galderma patient and stakeholder’s centricity and satisfaction.

Job Responsibilities

Understand and translate into Medical Affairs strategy and plans, the unmet medical needs and patient access needs to contribute to impactful patient outcomes.
Lead the integrated evidence generation plan in collaboration the cross functional nemolizumab team.
Be the medical strategy lead for the non-interventional studies and IIT involving nemolizumab.
In collaboration with the Global Medical Indication Lead, Develop and implement medical strategy for nemolizumab in Prurigo Nodularis and Atopic Dermatitis.
Ensure the development and implementation of an effective franchise medical communication strategy and plan for each nemolizumab indications linked to the annual brand plan and the Global Integrated project plan.
Lead the medical communication strategy, aligned with global medical strategy, local countries needs and ensure execution of key activities.
Lead the scientific collaboration with the medical community, building, strengthening the global external expert relationship.
Support identification and collaboration with global professional societies to help improve patients’ outcomes in atopic dermatitis and prurigo nodularis.
Develop and maintain best in class external engagement plan with multi stakeholders in Dermatology.
Support Medical scientific review of business development opportunities in the therapeutic area of focus.
Develop internal training material related to disease state, medical strategy and new nemolizumab data.
Ensure local countries have the required material to drive successful medical launch strategy.
Ensure Franchise Medical Affairs activities are designed and executed in compliance with companywide policy guidelines and medical quality standards.

Requirements

Medical Degree (MD), Medical scientific PhD or another adequate Natural Science (PharmD) higher degree is required, a Dermatology or Immunology expertise will be important
8 + years in the industry including a successful experience in US, regional or global medical affairs role
Pre-launch/launch Experience with specialty medicines in the field of specialty product in dermatology/immunology/allergy/rheumatology required (i.e.: biologics, systemics)
Business acumen and market knowledge is required
Leadership Capability
Innovative thinking, good judgment, and sense of ethics.
Excellent communication and interpersonal skills to deal with key opinion leaders and the medical/scientific communities at large.
Strong interpersonal skills - ability to interact with all levels within the organization and to deal with key opinion leaders and the medical/scientific communities at large.
Ability to think strategically to guide publication-related activities in accordance with industry standards and good publication practices
Experience in phase 4 program
Strong budget planning & execution expertise